Supplementary Table 1.
Author | Year | 1) Define the source of information (survey, record review) | 2) List inclusion and exclusion criteria for exposed and unexposed subjects (cases and controls) or refer to previous publications | 3) Indicate time period used for identifying patients | 4) Indicate whether or not subjects were consecutive if not population-based | 5) Indicate if evaluators of subjective components of study were masked to other aspects of the status of the participants | 6) Describe any assessments undertaken for quality assurance purposes | 7) Explain any patient exclusions from analysis | 8) Describe how confounding was assessed and/or controlled. | 9) If applicable explain how missing data were handled in the analysis | 10) Summarize patient response rates and completeness of data collection | 11) Clarify what follow-up, if any, was expected and the percentage of patients for which incomplete data or follow-up was obtained | Total quality score |
Iryna et al | 2007 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 8 |
Parveen et al | 2012 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 8 |
Margaret et al | 2014 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 9 |
Verelst et al | 2014 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 9 |
Stephen et al | 2015 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 7 |
Jennifer et al | 2015 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 8 |
Akashi et al | 2016 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 6 |
Elfalet et al | 2018 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 9 |
Bikila et al | 2019 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 9 |
The study quality was assessed according to the 11 items recommended by the Agency for Healthcare Research and Quality (AHRQ) for cross-sectional studies. 1 point if the item was contemplated in the study, 0 point if the item was not, and unable to determine. 1 = “Yes”, 0 = “No”, “Unable to determine”, or “Not applicable”